Neck pain and fever after peginterferon alpha-2a;Halsschmerzen und fieber nach peginterferon alpha-2a

Praxis

Volumn 96, Issue 6, 2007, Pages 205-207

  Moser, C ^a   Furrer, J ^a   Ruggieri, F ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Antibodies; Melanoma; Peginterferon; Thyroiditis

Indexed keywords

EID: 33847075097     PISSN: 16618157     EISSN: 16618165     Source Type: Journal    
DOI: 10.1024/1661-8157.96.6.205     Document Type: Article

References (14)

1. Volkenandt M, Hausschild A, Garbe C. Adjuvante medikamentöse Therapie des malignen Melanoms, Der Onkologe 2004; 10:710-716 (Pubitemid 39145205)
2. Wheatley K, Ives N, Hancock B, Gore M, Eggermont A, Suici S. Does adjuvant interferon-alpha for high-risk melanoma provide a worthwhile benefit? A meta-analysis of the randomised trials. Cancer Treat Rev. 2003; 29:241-252 (Pubitemid 37069655)
3. Pirard D, Heenen M, Melot C,Vereecken P. Interferon Alpha as Adjuvant Postsurgical Treatment of Melanoma: A Meta-Analysis. Dermatology 2004;208:43-48 (Pubitemid 38142333)
4. Fattovich G, Giustina G, Favarato S Ruol A. A survey of adverse events in 11 241 patients with chronic viral hepatitis treated with alfa interferon. Journal of hepatology 1996; 24:38-47
5. Koh L, Greenspan F, Yea P. Interferon-Alpha Induced Thyroid Dysfunction: Three Cllinical Presentations an a Review of the Literatur. Thyroid 1997; 7: 891-896 (Pubitemid 28041664)
6. Windemuth D, Bacharach-Buhles M, Hoffmann K, Altmeyer P. Depressivität mit Suizidalität als Nebenwirkung der Hoch-dosistherapie mit Interferon-alpha. Hautarzt 1999; 50: 266-269 (Pubitemid 29200324)
7. Dumoulin FL, Leifeld L, Sauerbruch T, Spengler U. Autoimmunity induced by interferon-Alpha therapy for chronic viral hepatitis. Biomed & Pharmacother 1999; 53: 242-254
8. Satoru K et al. HLA antigens in patients with interferon-alpha-induced autoimmune thyroid disordrs in chronic hepatitis C. Journal of Hepatology 1999; 30: 794-800
9. Preziati D et al. Autoimmunity and thyroid function in patients with chronic active hepatitis treated with recombinant interferon alpha-2a.European Journal of Endocrinology 1995; 132: 587-593
10. Roti E et al. Multiple Changes in Thyroid Function in Patients with Chronic Active HCV Hepatitis Treated with Recombinant Interferon-Alpha. The American Journal of Medicine; 101: 482-487
11. Fernandez-Soto L et al. Increased Risk of Autoimmune Thyroid Disease in Hepatitis C vs Hepatitis B Before, During and After Discontinuing Interferon Therapy. Arch Intern Med1998; 158: 1445-1448 (Pubitemid 28317761)
12. Custro N et al. Prospective study in thyroid autoimmunity and dysfunction related to chronic hepatitis C and interferon therapy. J. Endocrinol. Invest. 1997; 20: 374-380
13. Falashi P, Martocchia A, D'Urso R, Proietti A. Subacute thyroiditis during interferon-alpha therapy for chronic hepatitis C. J Endocrinol Invest 1997; 20: 24-28. (Pubitemid 27149662)
14. Gonzales-Fernandez B, Arranz A, Penarubia J.M and Marazuela M. Subacute thyroiditis associated with Interferon- 2a Therapy. Horm Metab Res. 1995 Jan;27(1):45-6.